Working in silos, change will not occur. WBC convenes with our Partners, Champions, and Sponsors to move faster together toward our action initiative goals.
Join us for Our Annual Action for Impact Summit!
WBC’s Annual Action for Impact Summit unites thousands of attendees on a fully interactive platform, enabling participants to network, connect, and exchange ideas, innovations, and impact in real time.
WOMEN CEO REPORT
Natalie C. Holles is the CEO of Third Harmonic Bio, Inc., a biotechnology company focused on developing novel therapies for allergic and inflammatory diseases. Holless leadership is defined by a commitment to advancing innovative drug development and addressing unmet medical needs. With a strong background in biotechnology and clinical research, she has been instrumental in guiding Third Harmonic Bio through critical stages of research and clinical trials. Her strategic vision includes leveraging cutting-edge science to develop transformative therapies and improve patient outcomes. Under her guidance, Third Harmonic Bio continues to make significant strides in advancing its therapeutic pipeline and contributing to the field of allergy and immunology.
